Supriya Lifescience IPO en | IPO Detailed News | 1302877/37
  • BUSINESS ENQUIRY : +91 80122 78000
      CUSTOMER SUPPORT : 044 4032 9999
  • BUSINESS ENQUIRY : +91 80122 78000   CUSTOMER SUPPORT : 044 4032 9999
YOU ARE ON THE NEW Goodwill WEBSITE, ACCESS THE OLD WEBSITE Click Here
16-Aug-2022 EOD 15 mins delay  NIFTY  17,825.25  [127.10]commodity-trading-and-shares-brokers-in-indiaAdani-Ports  824.15   [4.54]   |   Apollo-Hospitals  4349.40   [0.85]   |   Asian-Paints  3501.00   [2.13]   |   Axis-Bank  764.65   [0.54]   |   B-P-C-L  345.90   [3.59]   |   Bajaj-Auto  4091.15   [1.32]   |   Bajaj-Finance  7286.10   [-0.32]   |   Bajaj-Finserv  15915.75   [0.95]   |   Bharti-Airtel  704.10   [-0.79]   |   Britannia-Inds  3690.45   [0.84]   |   Cipla  1034.55   [0.72]   |   Coal-India  222.90   [0.56]   |   Divi's-Lab  3732.00   [0.16]   |   Dr-Reddy's-Labs  4297.80   [0.87]   |   Eicher-Motors  3338.05   [3.98]   |   Grasim-Inds  1591.55   [-1.91]   |   H-D-F-C  2484.15   [1.13]   |   HCL-Technologies  958.20   [0.19]   |   HDFC-Bank  1502.15   [1.14]   |   HDFC-Life-Insur  570.60   [4.71]   |   Hero-Motocorp  2817.00   [2.00]   |   Hind-Unilever  2644.50   [1.91]   |   Hindalco-Inds  428.90   [-1.68]   |   ICICI-Bank  879.25   [0.55]   |   IndusInd-Bank  1084.45   [0.37]   |   Infosys  1596.45   [0.15]   |   ITC  310.55   [0.65]   |   JSW-Steel  673.85   [-0.64]   |   Kotak-Mah-Bank  1846.35   [0.28]   |   Larsen-and-Toubro  1848.90   [0.13]   |   M-and-M  1288.30   [2.29]   |   Maruti-Suzuki  9003.70   [3.50]   |   Nestle-India  19682.95   [0.71]   |   NTPC  158.75   [0.16]   |   O-N-G-C  139.95   [0.54]   |   Power-Grid-Corpn  228.85   [0.35]   |   Reliance-Industr  2651.30   [0.70]   |   SBI-Life-Insuran  1309.60   [1.79]   |   Shree-Cement  21440.55   [1.36]   |   St-Bk-of-India  525.95   [-0.90]   |   Sun-PharmaInds  914.60   [0.13]   |   Tata-Consumer  779.50   [2.10]   |   Tata-Motors  489.85   [2.58]   |   Tata-Steel  113.00   [0.31]   |   TCS  3392.70   [-0.26]   |   Tech-Mahindra  1077.70   [1.11]   |   Titan-Company  2493.85   [0.89]   |   UltraTech-Cem  6656.00   [1.47]   |   UPL  788.55   [-0.04]   |   Wipro  437.10   [0.23]   |   
USEFUL
LINKS

IPO News Details

Supriya Lifescience IPO ends with robust subscription
21-Dec-21   11:07 Hrs IST

The initial public offer (IPO) of Supriya Lifescience received bids for 1,03,89,66,318 shares as against 1,45,28,299 shares on offer. The issue was subscribed 71.51 times.

The non institutional investors category was subscribed 161.22 times. The retail investors category was subscribed 56.01 times. The qualified institutional buyers category was subscribed 31.83 times.

The issue opened for bidding on 16 December 2021 and it closed on 20 December 2021. The price band of the IPO was fixed at Rs 265-274 per share.

Ahead of the IPO, the company on 15 December 2021, finalized allocation of 1,14,96,351 equity shares to anchor investors at an allocation price of Rs 274 per share, aggregating to Rs 315 crore.

The IPO comprised of fresh issue of equity shares worth up to Rs 200 crore and an offer for sale of Rs 500 crore by existing shareholders.

Satish Waman Wagh, the promoter of the company, currently holds an aggregate of 7,26,42,390 equity shares, aggregating to 99.26% of the pre-offer issued share capital. The post IPO shareholding for the same is expected to be around 68.24%.

The objectives for the fresh issue are funding capital expenditure requirements of Rs 92.3 crore, Rs 60 crore for repayment/pre-payment, in full or part of borrowings and remaining amount will be used for general corporate purposes.

Supriya Lifescience is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development. As of 31 October 2021, the company has niche product offerings of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anesthetics, vitamin, anti-asthmatic and antiallergic.

The business operations of the company are supported by a modern manufacturing facility located in Parshuram Lote, Maharashtra, which is approximately 250 km from Mumbai. Its manufacturing facility has received approvals from USFDA, EDQM TGA-Australia, KFDA-Korea, PMDA Japan, NMPA (previously known as SFDA)- China, Health Canada, in relation to the products being exported to the relevant jurisdictions.

The manufacturing facility is spread across 23,806 sq.mt, having reactor capacity of 332 KL/ day and seven cleanrooms. In addition, company has acquired a plot of land, admeasuring 12,551 sq.mt, near the present manufacturing facility, wherein the Company intends to expand its manufacturing infrastructure.

The company intends to continue to drive R&D initiatives towards the development of innovative APIs. It also intends to improve its R&D capabilities, with a focus on capturing more high-value first-to-market opportunities in key international markets, as well as leveraging broad product basket to enhance market position globally.

The company reported a net profit of Rs 65.96 crore on sales of Rs 224.80 crore in six month ended September 2021.

Powered by Capital Market - Live News

Attention Investor
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. Prevent Unauthorized Transactions in your Demat account\Trading account: Update your Mobile Number with your Depository Participant\Exchange. Receive alerts on your Registered Mobile for all debit and other important transactions in your Demat account\Trading account directly from Depository\Exchange on the same day.........issued in the interest of investors.
The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by our employees, our servants, and us.
Please DO NOT disclose your User ID and/or Passwords to any person, even Goodwill staff never ask you to share the same. Goodwill is NEITHER liable for any loss arising from your sharing of your password with anyone, NOR from its consequent unauthorized use.